Ultragenyx Pharmaceutical Market Sentiment

Ultragenyx Pharmaceutical Inc

RARENASDAQ

Trade with Public

$26.24

0.752.94%

At close: Aug 18, 5:00 PM EST

$29.20

3.7114.55%

Pre-Market: 6:09 AM EST

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Ultragenyx Pharmaceutical Market Sentiment

Market sentiment signals for Ultragenyx Pharmaceutical (RARE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▼ 15.7% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Overweight

26 analysts

Options Flow (P/C)

—

Avg Consensus PT

$68

+133.0%

Highest Price Target

$140

+379.5%

Piper Sandler

Lowest Price Target

$25

-14.4%

Goldman Sachs

Short Interest

15.7%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 20, 2026	Cantor Fitzgerald	Kristen Kluska—	+252.7%	$96 → $103	Maintained	Overweight
Aug 10, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+71.2%	$50 → $50	Maintained	Buy
Aug 5, 2026	Wells Fargo	Benjamin Burnett—	+54.1%	$47 → $45	Maintained	Overweight
Aug 4, 2026	Guggenheim	Debjit Chattopadhyay—	+19.9%	$43 → $35	Maintained	Buy
Jul 7, 2026	RBC Capital	Luca Issi—	+37.0%	$35 → $40	Maintained	Outperform
May 21, 2026	Cantor Fitzgerald	Kristen Kluska—	+228.8%	$84 → $96	Maintained	Overweight
May 8, 2026	Wedbush	Laura Chico—	-11.0%	$27 → $26	Maintained	Neutral
May 8, 2026	Guggenheim	Debjit Chattopadhyay—	+47.3%	$52 → $43	Maintained	Buy
May 6, 2026	Wells Fargo	Benjamin Burnett—	+61.0%	$45 → $47	Maintained	Overweight
May 6, 2026	Wedbush	Laura Chico—	-11.0%	$27 → $26	Maintained	Neutral
Apr 29, 2026	Barclays	Eliana Merle—	+47.3%	$44 → $43	Maintained	Overweight
Apr 16, 2026	Morgan Stanley	Jeffrey Hung—	+129.5%	$50 → $67	Maintained	Overweight
Mar 24, 2026	Goldman Sachs	Salveen Richter—	-14.4%	$61 → $25	Downgrade	Buy→Neutral
Mar 12, 2026	JP Morgan	Anupam Rama—	+153.4%	$120 → $74	Maintained	Overweight
Feb 18, 2026	Canaccord Genuity	Whitney Ijem—	+170.5%	$128 → $79	Maintained	Buy
Feb 18, 2026	Evercore ISI Group	Liisa Bayko—	+16.4%	$37 → $34	Maintained	Outperform
Feb 17, 2026	Evercore ISI Group	Liisa Bayko—	+26.7%	$39 → $37	Maintained	Outperform
Feb 17, 2026	Wedbush	Laura Chico—	-14.4%	$25 → $25	Maintained	Neutral
Feb 17, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+71.2%	$60 → $50	Maintained	Buy
Feb 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+105.5%	$60 → $60	Maintained	Buy
Jan 5, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+105.5%	$80 → $60	Maintained	Buy
Jan 5, 2026	Guggenheim	Debjit Chattopadhyay—	+78.1%	$64 → $52	Maintained	Buy
Jan 2, 2026	B of A Securities	Tazeen Ahmad—	+98.6%	$72 → $58	Maintained	Buy
Dec 30, 2025	Leerink Partners	Joseph Schwartz—	+139.7%	$80 → $70	Maintained	Outperform
Dec 30, 2025	Baird	Joel Beatty—	+61.0%	$72 → $47	Maintained	Outperform